Skip to content

Cannabis: all studies

Page 70 of 289: studies 691 to 700 of 2,882, newest first. Back to the cannabis overview

Research

Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms

International Journal of Environmental Research and Public Health November 30, 2021 Valerio Ricci, Giovanni Martinotti, Franca Ceci et al. 33 citations

BACKGROUND: The Duration of Untreated Psychosis (DUP) is the time between the first-episode psychosis (FEP) and the initiation of antipsychotic treatment. It is an important predictor of several disease-related outcomes in psychotic disorders. The aim of this manuscript is investigating the influence of cannabis on the DUP and its clinical correlates. METHODS: During years 2014-2019, sixty-two...

Cannabis Use, Schizotypy and Kamin Blocking Performance

Frontiers in Psychiatry November 23, 2021 Christopher Dawes, Andrea Bickerdike, Cian O’Neill et al. 3 citations

Cannabis use has been associated with increased risk for a first episode of psychosis and inappropriate assignment of salience to extraneous stimuli has been proposed as a mechanism underlying this association. Psychosis-prone (especially schizotypal) personality traits are associated with deficits in associative learning tasks that measure salience allocation. The aim of this study was to...

DOI: 10.3389/fpsyt.2021.633476 (opens in new tab) Cannabis Schizotypy Psychosis Salience neuroscience +5

Multimodal MRI data fusion reveals distinct structural, functional and neurochemical correlates of heavy cannabis use

Addiction Biology November 22, 2021 Dusan Hirjak, Mike M. Schmitgen, Florian Werler et al. 33 citations

Heavy cannabis use (HCU) is frequently associated with a plethora of cognitive, psychopathological and sensorimotor phenomena. Although HCU is frequent, specific patterns of abnormal brain structure and function underlying HCU in individuals presenting without cannabis-use disorder or other current and life-time major mental disorders are unclear at present. This multimodal magnetic resonance...

"ABERRANT" NEURONAL STIMULATION AND "CANNABIS PSYCHOSIS" - HYPOTHESIS TO A BIOLOGICAL PLAUSIBILITY!

Psychiatria Danubina November 17, 2021 Nileswar Das 3 citations

Western democracies continue to 'legalize recreational cannabis use' after its 'medicinal approval', while India continues to debate whether to 'decriminalize' cannabis or not. One of the strongest arguments against cannabis decriminalization is cannabis dependence and the risk of psychosis, at-least in the vulnerable groups. Endocannabinoids are involved in neuronal proliferation and...

DOI: 10.24869/psyd.2021.280 (opens in new tab) Cannabidiol Psychosis Effects of cannabis Schizophrenia object-oriented programming +1

Policy in focus: Is psilocybin the next cannabis?

Canadian Medical Association Journal November 14, 2021 Greg Basky 7 citations

Research interest in the therapeutic use of psilocybin, or "magic mushrooms," is growing alongside a "wild west" of dispensaries in Canada and the United States. The past decade has seen a revival of research exploring the clinical use of psychedelics in treating depression, addiction,

Δ 9-Tetrahydrocannabinol During Adolescence Reprograms the Nucleus Accumbens Transcriptome, Affecting Reward Processing, Impulsivity, and Specific Aspects of Cocaine Addiction-Like Behavior in a Sex-Dependent Manner.

The International Journal of Neuropsychopharmacology November 12, 2021 Javier Orihuel, Roberto Capellán, David Roura-Martínez et al.

Cannabis exposure during adolescence is associated with emotional and motivational alterations that may entail an enhanced risk of developing psychiatric disorders. In rodent models, exposure to cannabinoids during adolescence leads to increased self-administration of opiates and cocaine, however, the psychological and neural mechanisms and the sex-specificity of this phenomenon are largely...

Motivations for cannabis use in youth with first episode psychosis: a scoping review

Psychosis November 12, 2021 Amar Ghelani, G. Armstrong, A. Haywood

ABSTRACT Background Youth in First Episode Psychosis (FEP) programs have high rates of cannabis use and consumption is associated with negative treatment outcomes. Motivations for use in this group are under-studied and investigating reasons for use can aid in the development of engagement strategies. Methods This scoping review uses the framework proposed by Arksey & O’Malley and PRISMA ScR to...

HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits.

The International Journal of Neuropsychopharmacology November 12, 2021 Benjamin Z Roberts, Arpi Minassian, Adam L. Halberstadt et al.

HIV-associated neurocognitive disorder (HAND) is commonly observed in persons living with HIV (PWH) and is characterized by cognitive deficits implicating disruptions of fronto-striatal neurocircuitry. Such circuitry is also susceptible to alteration by cannabis and other drugs of abuse. PWH use cannabis at much higher rates than the general population, thus prioritizing the characterization of...

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.

Psychopharmacology November 4, 2021 Joanna Kuć, Hannes Kettner, Fernando E. Rosas et al. 37 citations

RATIONALE: Classic psychedelics are currently being studied as novel treatments for a range of psychiatric disorders. However, research on how psychedelics interact with other psychoactive substances remains scarce. OBJECTIVES: The current study aimed to explore the subjective effects of psychedelics when used alongside cannabis. METHODS: Participants (n = 321) completed a set of online surveys...

DOI: 10.1007/s00213-021-05999-1 (opens in new tab) Full text (opens in new tab) Psychedelics Cannabis/marijuana/weed Drug interactions Altered states +1

Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: a neuroimaging meta-regression analysis

bioRxiv (Cold Spring Harbor Laboratory) November 3, 2021 Brandon Gunasekera, Cathy Davies, Grace Blest‐hopley et al. preprint

Abstract Background The neurobiological mechanisms underlying the effects of delta-9-tetrahydrocannabinol (THC) remain unclear. Here, we examined the spatial acute effect of THC on human on regional brain activation or blood flow (hereafter called ‘activation signal’) in a ‘core’ network of brain regions that subserve a multitude of processes. We also investigated whether the neuromodulatory...

DOI: 10.1101/2021.11.01.466757 (opens in new tab) Full text (opens in new tab) Precuneus Human brain Middle temporal gyrus Neuroimaging +6